Reactivation of human polyomaviruses in immunocompromised states

Journal of NeuroVirology

Volumn 20, Issue 1, 2014, Pages 1-8

  Wiedinger, Kari ^a   Bitsaktsis, Constantine ^a   Chang, Sulie ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

Alcohol abuse; Immunosuppression; Polyomavirus; Reactivation

Indexed keywords

EFALIZUMAB; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NATALIZUMAB; RITUXIMAB; TACROLIMUS;

ALCOHOL ABUSE; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; POLYOMA VIRUS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

POLYOMAVIRUS;

HUMANS; IMMUNOCOMPROMISED HOST; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; VIRUS LATENCY;

EID: 84896710113     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0234-x     Document Type: Article

References (80)

1. Abend JR, Low JA, Imperiale MJ (2007) Inhibitory effect of gamma interferon on BK virus gene expression and replication. J Virol 81(1):272-279
2. Andoniou CE, Andrews DM, Degli-Esposti MA (2006) Natural killer cells in viral infection: more than just killers. Immunol Rev 214:239-250. doi: 10.1111/j.1600-065X.2006.00465.x
3. Atwood WJ, Amemiya K, Traub R, Harms J, Major EO (1992) Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 190(2):716-723
4. Ault GS (1997) Activity of JC virus archetype and PML-type regulatory regions in glial cells. J Gen Virol 78(Pt 1):163-169
5. Bag AK, Cure JK, Chapman PR, Roberson GH, Shah R (2010) JC virus infection of the brain. AJNR Am J Neuroradiol 31(9):1564-1576. doi: 10.3174/ajnr.A2035
6. Balduzzi A, Lucchini G, Hirsch H, Basso S, Cioni M, Rovelli A, Zincone A, Grimaldi M, Corti P, Bonanomi S (2010) Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient. Bone Marrow Transplant 46(7):987-992
7. Barzon L, Squarzon L, Militello V, Trevisan M, Porzionato A, Macchi V, De Caro R, Palu G (2009) WU and KI polyomaviruses in the brains of HIV-positive patients with and without progressive multifocal leukoencephalopathy. J Infect Dis 200(11):1755-1758. doi: 10.1086/648095
8. Bayliss J, Karasoulos T, Bowden S, Glogowski I, McLean CA (2011) Immunosuppression increases latent infection of brain by JC polyomavirus. Pathology 43(4):362-367. doi: 10.1097/PAT.0b013e3283463558
9. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM, Khoo SH (2004) Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. J Clin Virol 29(4):224-229
10. Bellizzi A, Nardis C, Anzivino E, Rodio D, Fioriti D, Mischitelli M, Chiarini F, Pietropaolo V (2012) Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. J Neurovirol 18(1):1-11. doi: 10.1007/s13365-012-0080-7
11. Berger JR, Houff S (2006) Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res 28(3):299-305. doi: 10.1179/016164106X98198
12. Blackburn SD, Crawford A, Shin H, Polley A, Freeman GJ, Wherry EJ (2010) Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. J Virol 84(4):2078-2089. doi: 10.1128/JVI.01579-09
13. Brown LAS, Cook RT, Jerrells TR, Kolls JK, Nagy LE, Szabo G, Wands JR, Kovacs EJ (2006) Acute and chronic alcohol abuse modulate immunity. Alcohol Clin Exp Res 30(9):1624-1631
14. Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, Bennett CL (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10(8):816-824. doi: 10.1016/S1470-2045(09)70161-5
15. Carter JJ, Paulson KG, Wipf GC, Miranda D, Madeleine MM, Johnson LG, Lemos BD, Lee S, Warcola AH, Iyer JG, Nghiem P, Galloway DA (2009) Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 101(21):1510-1522. doi: 10.1093/jnci/djp332
16. Chapagain ML, Nerurkar VR (2010) Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. J Infect Dis 202(2):184-191
17. Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ (2009) Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med 361(11):1067-1074. doi: 10.1056/NEJMoa0904267
18. Comoli P, Azzi A, Maccario R, Basso S, Botti G, Basile G, Fontana I, Labirio M, Cometa A, Poli F (2004) Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 78(8):1229-1232
19. Dalianis T, Hirsch HH (2013) Human polyomaviruses in disease and cancer. Virology 437(2):63-72. doi: 10.1016/j.virol.2012.12.015
20. De Gascun CF, Carr MJ (2013) Human polyomavirus reactivation: disease pathogenesis and treatment approaches. Clinical and Developmental Immunology 2013: 27. doi: 10.1155/2013/373579
21. DeCaprio JA, Garcea RL (2013) A cornucopia of human polyomaviruses. Nat Rev Microbiol 11(4):264-276. doi: 10.1038/nrmicro2992
22. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54(2):275-283. doi: 10.1016/0092-8674(88)90559-4
23. Degener A, Pietropaolo V, Di Taranto C, Rizzuti V, Ameglio F, Cordiali Fei P, Caprilli F, Capitanio B, Sinibaldi L, Orsi N (1997) Detection of JC and BK viral genome in specimens of HIV-1 infected subjects. New Microbiol 20(2):115-122
24. Delbue S, Tremolada S, Elia F, Carloni C, Amico S, Tavazzi E, Marchioni E, Novati S, Maserati R, Ferrante P (2010) Lymphotropic polyomavirus is detected in peripheral blood from immunocompromised and healthy subjects. J Clin Virol 47(2). doi: 156-60.10.1016/j.jcv.2009.11.029
25. Dörries K (2002) Latent and persistent polyomavirus infection. Human Polyomaviruses: Mol Clin Perspect 197-235
26. Du Pasquier RA, Clark KW, Smith PS, Joseph JT, Mazullo JM, De Girolami U, Letvin NL, Koralnik IJ (2001) JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol 7(4):318-322. doi: 10.1080/13550280152537175
27. Du Pasquier RA, Kuroda MJ, Zheng Y, Jean-Jacques J, Letvin NL, Koralnik IJ (2004) A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127(9):1970-1978
28. Feng H, Shuda M, Chang Y, Moore PS (2008). Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319(5866). doi: 1096-100.10.1126/science.1152586
29. Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO (2012) Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 25(3):471-506. doi: 10.1128/CMR.05031-11
30. Friedman H, Newton C, Klein TW (2003) Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 16(2):209-219
31. Gardner SD, Field AM, Coleman DV, Hulme B (1971) New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1(7712):1253-1257
32. + T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 85(14):7256-7263. doi: 10.1128/JVI.02506-10
33. Goldberg MV, Maris CH, Hipkiss EL, Flies AS, Zhen L, Tuder RM, Grosso JF, Harris TJ, Getnet D, Whartenby KA (2007) Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood 110(1):186-192
34. Hirsch HH, Steiger J (2003) Polyomavirus Bk. Lancet Infect Dis 3(10):611-623
35. Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC (1991) Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology 41(11):1733. doi: 10.1212/wnl.41.11.1733
36. Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, Moore PS, Becker JC (2010) Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 84(14):7064-7072
37. + T-cell responses identified in Merkel cell carcinomas and blood. Clin Cancer Res 17(21):6671-6680. doi: 10.1158/1078-0432.CCR-11-1513
38. Jerrells TR (2002) Association of alcohol consumption and exaggerated immunopathologic effects in the liver induced by infectious organism. Front Biosci 7:d1487-d1493
39. Jiang M, Abend JR, Johnson SF, Imperiale MJ (2009). The role of polyomaviruses in human disease. Virology 384(2). doi: 266-73.10.1016/j.virol. 2008.09.027S0042-6822(08)00636-3
40. Johnson EM, Wortman MJ, Dagdanova AV, Lundberg PS, Daniel DC (2013) Polyomavirus JC in the context of immunosuppression: a series of adaptive, DNA replication-driven recombination events in the development of progressive multifocal leukoencephalopathy. Clin Dev Immunol 197807. doi: 10.1155/2013/197807
41. Kalvatchev Z, Tsekov I, Vladimirov V, Paskalev E, Zlatkov B, Filipov Z, Gicheva M (2012) Human BK polyomaviral activity in patients with renal transplants. Med Pregled 48(4):46-50
42. Kean JM, Rao S, Wang M, Garcea RL (2009) Seroepidemiology of human polyomaviruses. PLoS Pathog 5(3):e1000363. doi: 10.1371/journal.ppat.1000363
43. Khalili K, Wang D, Ehlers B, Khan ZM, Vanchiere JA, Berger J, Koralnik I, Hirsch HH, Lautenschlager I, Korup S (2013) 5th International Conference on Polyomaviruses and Human Diseases: Basic and Clinical Perspectives
44. Khanna N, Wolbers M, Mueller NJ, Garzoni C, Du Pasquier RA, Fux CA, Vernazza P, Bernasconi E, Viscidi R, Battegay M (2009) JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol 83(9):4404-4411
45. Knowles WA, Pillay D, Johnson MA, Hand JF, Brown DW (1999). Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol 59(4). doi: (SICI)1096-9071/(SICI)1096- 9071(199912)59:4<474::AID-JMV9>3.0.CO;2-W
46. Korup S, Rietscher J, Calvignac-Spencer S, Trusch F, Hofmann J, Moens U, Sauer I, Voigt S, Schmuck R, Ehlers B (2013) Identification of a novel human polyomavirus in organs of the gastrointestinal tract. PLoS ONE 8:e58021. doi: 10.1371/journal.pone.0058021
47. Kraemer C, Evers S, Nolting T, Arendt G, Husstedt IW (2008) Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy. J Neurol 255(4):526-531. doi: 10.1007/s00415-008-0731-z
48. Kumar A, Kantele A, Järvinen T, Chen T, Kavola H, Sadeghi M, Hedman K, Franssila R (2012) Trichodysplasia spinulosa-associated polyomavirus (TSV) and Merkel cell polyomavirus: correlation between humoral and cellular immunity stronger with TSV. PLoS One 7(9):e45773
49. Marcondes MC, Watry D, Zandonatti M, Flynn C, Taffe MA, Fox H (2008) Chronic alcohol consumption generates a vulnerable immune environment during early SIV infection in rhesus macaques. Alcohol Clin Exp Res 32(9):1583-1592. doi: 10.1111/j.1530-0277.2008.00730.x
50. Mengel M, Marwedel M, Radermacher J, Eden G, Schwarz A, Haller H, Kreipe H (2003) Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 18(6):1190-1196
51. Meyerholz DK, Edsen-Moore M, McGill J, Coleman RA, Cook RT, Legge KL (2008) Chronic alcohol consumption increases the severity of murine influenza virus infections. J Immunol 181(1):641-648
52. Mischitelli M, Fioriti D, Videtta M, Degener A, Antinori A, Cinque P, Giordano A, Pietropaolo V (2005) Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development. J Cell Physiol 204(3):913-918
53. Molina PE, Happel KI, Zhang P, Kolls JK, Nelson S (2010) Focus on: alcohol and the immune system. Alcohol Res Health 33(1):97-108
54. Nguyen NL, Le BM, Wang D (2009) Serologic evidence of frequent human infection with WU and KI polyomaviruses. Emerg Infect Dis 15(8):1199-1205. doi: 10.3201/eid1508.090270
55. Orba Y, Suzuki T, Makino Y, Kubota K, Tanaka S, Kimura T, Sawa H (2010). Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling. J Biol Chem 285(2). doi: 1544-54.10.1074/jbc.M109.064311
56. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971) Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1(7712):1257-1260
57. Pang M, Bala S, Kodys K, Catalano D, Szabo G (2011) Inhibition of TLR8- and TLR4-induced Type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytes. BMC Immunol 12:55. doi: 10.1186/1471-2172-12-55
58. Persidsky Y, Ho W, Ramirez SH, Potula R, Abood ME, Unterwald E, Tuma R (2011) HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions. Brain Behav Immun 25:S61-S70
59. Poonia B, Nelson S, Bagby GJ, Zhang P, Quniton L, Veazey RS (2006) Chronic alcohol consumption results in higher simian immunodeficiency virus replication in mucosally inoculated rhesus macaques. AIDS Res Hum Retrovir 22(6):589-594. doi: 10.1089/aid.2006.22.589
60. Romagnoli L, Wollebo HS, Deshmane SL, Mukerjee R, Del Valle L, Safak M, Khalili K, White MK (2009) Modulation of JC virus transcription by C/EBPbeta. Virus Res 146(1-2):97-106. doi: 10.1016/j.virusres.2009.09.005
61. Sadler GM, Halbert AR, Smith N, Rogers M (2007) Trichodysplasia spinulosa associated with chemotherapy for acute lymphocytic leukaemia. Aust J Dermatol 48(2):110-114
62. Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA (2004) Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retrovir 20(2):151-155. doi: 10.1089/ 088922204773004860
63. Schowalter RM, Reinhold WC, Buck CB (2012) Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS ONE 7(7):e42181
64. Shiu C, Barbier E, Di Cello F, Choi HJ, Stins M (2007) HIV-1 gp120 as well as alcohol affect blood-brain barrier permeability and stress fiber formation: involvement of reactive oxygen species. Alcohol Clin Exp Res 31(1):130-137. doi: 10.1111/j.1530-0277.2006.00271.x
65. Sidhu N, McCutchan JA (2010) Unmasking of PML by HAART: unusual clinical features and the role of IRIS. J Neuroimmunol 219(1):100-104
66. Spurgeon ME, Lambert PF (2013) Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology 435(1):118-130. doi: 10.1016/j.virol.2012.09.029
67. Stoltz DA, Nelson S, Kolls JK, Zhang P, Bohm RP Jr, Murphey-Corb M, Bagby GJ (2000) In vitro ethanol suppresses alveolar macrophage TNF-alpha during simian immunodeficiency virus infection. Am J Respir Crit Care Med 161(1):135-140. doi: 10.1164/ajrccm.161.1.9905016
68. Szabo G, Catalano D, White B, Mandrekar P (2004) Acute alcohol consumption inhibits accessory cell function of monocytes and dendritic cells. Alcohol Clin Exp Res 28(5):824-828
69. Tan CS, Bord E, Broge TA Jr, Glotzbecker B, Mills H, Gheuens S, Rosenblatt J, Avigan D, Koralnik IJ (2012). Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy. J Acquir Immune Defic Syndr 60(3). doi: 244-8.10.1097/QAI.0b013e31825a313c
70. Traylen CM, Patel HR, Fondaw W, Mahatme S, Williams JF, Walker LR, Dyson OF, Arce S, Akula SM (2011) Virus reactivation: a panoramic view in human infections. Futur Virol 6(4):451-463. doi: 10.2217/fvl.11.21
71. Uleri E, Regan P, Dolei A, Sariyer IK (2013) SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells. Virol J 10:147. doi: 10.1186/1743-422X-10-147
72. Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 353(4):362-368. doi: 10.1056/NEJMoa051586
73. Van Den Brande JM, Peppelenbosch MP, Van Deventer SJ (2002) Treating Crohn's disease by inducing T lymphocyte apoptosis. Ann N Y Acad Sci 973:166-180
74. van der Meijden E, Janssens RW, Lauber C, Bavinck JNB, Gorbalenya AE, Feltkamp MC (2010a) Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog 6(7):e1001024
75. van der Meijden E, Janssens RW, Lauber C, Bouwes Bavinck JN, Gorbalenya AE, Feltkamp MC (2010b) Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog 6(7):e1001024. doi: 10.1371/journal.ppat.1001024
76. Vanchiere JA, Abudayyeh S, Copeland CM, Lu LB, Graham DY, Butel JS (2009) Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol 47(8):2388-2391. doi: 10.1128/JCM.02472-08
77. Wherry EJ (2011) T cell exhaustion. Nat Immunol 12(6):492-499
78. White MK, Safak M, Khalili K (2009) Regulation of gene expression in primate polyomaviruses. J Virol 83(21):10846-10856. doi: 10.1128/JVI.00542-09
79. White MK, Gordon J, Khalili K (2013) The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog 9(3):e1003206. doi: 10.1371/journal.ppat. 1003206
80. Wollebo HS, Safak M, Del Valle L, Khalili K, White MK (2011) Role for tumor necrosis factor-alpha in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol 233(1-2):46-53. doi: 10.1016/j.jneuroim. 2010.11.013